About GeneScience Pharmaceuticals
GeneScience Pharmaceuticals is a Healthcare company based in Changchun (China) founded in 1996. Genetically engineered pharmaceuticals are produced using recombinant technology. Its chief executive, as recorded, is Lei Jin. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms.
Company details
GeneScience Pharmaceuticals was founded in 1996 in Changchun, China, within the biotechnology and pharmaceuticals sector. Genetic engineering and recombinant technologies are employed to develop proprietary products, including GenLei Jintropin as a human growth hormone, Genfulin derived from rDNA, recombinant human granulocyte-macrophage stimulating factor gel used for burn treatment, and octreotide acetate applied in child growth therapies. Operations focus on manufacturing and distribution of these specialized treatments.
- Headquarters Changchun, China
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gensci-china.com
- Social LinkedIn
- InvestorsChina Huarong Asset Management
& 4 more
Funding Insights of GeneScience Pharmaceuticals
- Total Rounds 2
- Investors Count 5
All 2 funding rounds of GeneScience Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | Series A | – | IDG Capital, New Alliance Capital | – | |
| Mar 2021 | Series B | – | Efung Capital, Haitong Bank | – |
5 investors in total: 5 institutional.
Investors in GeneScience Pharmaceuticals
GeneScience Pharmaceuticals has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include China Huarong Asset Management, IDG Capital and New Alliance Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm | idgcapital.com | New York, United States | ||
PE firm invests in China | nac-capital.com | Shanghai, China | ||
| efung.cc | ||||
Investment banking services, corporate financing, and capital markets operations are conducted globally. | haitongib.com | |||
Asset management services are provided by China Huarong in China. | 1999 | chamc.com.cn | Beijing, China |
Investor details for GeneScience Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of GeneScience Pharmaceuticals
1 people are tracked at GeneScience Pharmaceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lei Jin | CEO | Leadership |
Complete people profiles for GeneScience Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of GeneScience Pharmaceuticals
2 dated milestones of GeneScience Pharmaceuticals across 25 years, from founding to its latest funding, stage changes and deals.
- Founded GeneScience Pharmaceuticals is founded.
- Funding First funding round.
Web traffic of GeneScience Pharmaceuticals
The website of GeneScience Pharmaceuticals (gensci-china.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 4.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genescience Pharmaceuticals
Complete news archive for GeneScience Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GeneScience Pharmaceuticals
GeneScience Pharmaceuticals was founded in 1996 and raised its 1st funding round 25 years after it was founded.
GeneScience Pharmaceuticals is headquartered in Changchun, China. It is registered at Changchun, Jilin, China.
Lei Jin is the CEO of GeneScience Pharmaceuticals, as recorded in our data.
GeneScience Pharmaceuticals was founded in 1996 in Changchun, China, within the biotechnology and pharmaceuticals sector. Genetic engineering and recombinant technologies are employed to develop proprietary products, including GenLei Jintropin as a human growth hormone, Genfulin derived from rDNA, recombinant human granulocyte-macrophage stimulating factor gel used for burn treatment, and octreotide acetate applied in child growth therapies. Operations focus on manufacturing and distribution of these specialized treatments.
GeneScience Pharmaceuticals has 5 investors. Key investors include China Huarong Asset Management, IDG Capital, New Alliance Capital, Efung Capital, and Haitong Bank.